MLTX
Price:
$52.14
Market Cap:
$3.29B
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.[Read more]
Industry
Biotechnology
IPO Date
2020-10-20
Stock Exchange
NASDAQ
Ticker
MLTX
According to MoonLake Immunotherapeutics’s latest financial reports and current stock price. The company's current Enterprise Value is 2.92B. This represents a change of 7.53% compared to the average of 2.71B of the last 4 quarters.
The mean historical Enterprise Value of MoonLake Immunotherapeutics over the last ten years is 759.94M. The current 2.92B Enterprise Value has changed 38.27% with respect to the historical average. Over the past ten years (40 quarters), MLTX's Enterprise Value was at its highest in in the December 2023 quarter at 3.17B. The Enterprise Value was at its lowest in in the June 2022 quarter at 92.10M.
Average
759.94M
Median
218.06M
Minimum
84.51M
Maximum
2.52B
Discovering the peaks and valleys of MoonLake Immunotherapeutics Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 836.24%
Maximum Annual Enterprise Value = 2.52B
Minimum Annual Increase = -49.41%
Minimum Annual Enterprise Value = 84.51M
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.52B | 836.24% |
2022 | 269.07M | 218.41% |
2021 | 84.51M | -49.41% |
The current Enterprise Value of MoonLake Immunotherapeutics (MLTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
957.57M
5-year avg
759.94M
10-year avg
759.94M
MoonLake Immunotherapeutics’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (0), greater than Day One Biopharmaceuticals, Inc. (234.86M), greater than Acumen Pharmaceuticals, Inc. (859.59M), greater than Amylyx Pharmaceuticals, Inc. (103.15M), greater than Aerovate Therapeutics, Inc. (209.72M), greater than Enliven Therapeutics, Inc. (43.34M), greater than Structure Therapeutics Inc. (1.04B), greater than Compass Therapeutics, Inc. (1.47B), greater than Ventyx Biosciences, Inc. (177.84M), greater than Nuvalent, Inc. (115.44M), less than Cerevel Therapeutics Holdings, Inc. (5.59B), less than Travere Therapeutics, Inc. (8.24B), greater than Arcellx, Inc. (1.86B), less than Akero Therapeutics, Inc. (4.06B), greater than 89bio, Inc. (1.70B), greater than Pliant Therapeutics, Inc. (885.64M), greater than null (792.38M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $503.69M | |
234.86M | $1.28B | |
859.59M | $106.34M | |
103.15M | $278.99M | |
209.72M | $73.92M | |
43.34M | $1.14B | |
1.04B | $1.64B | |
1.47B | $207.76M | |
177.84M | $166.17M | |
115.44M | $5.96B | |
5.59B | $8.19B | |
8.24B | $1.49B | |
1.86B | $4.15B | |
4.06B | $1.98B | |
1.70B | $939.48M | |
885.64M | $811.79M | |
792.38M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MoonLake Immunotherapeutics using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MoonLake Immunotherapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is MoonLake Immunotherapeutics's Enterprise Value?
What is the highest Enterprise Value for MoonLake Immunotherapeutics (MLTX)?
What is the 3-year average Enterprise Value for MoonLake Immunotherapeutics (MLTX)?
What is the 5-year average Enterprise Value for MoonLake Immunotherapeutics (MLTX)?
How does the current Enterprise Value for MoonLake Immunotherapeutics (MLTX) compare to its historical average?